Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Sorteer per
Keyphrases
Acute Leukemia
39%
Acute Lymphoblastic Leukemia
31%
Acute Myeloid Leukemia
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
35%
B-cell Acute Lymphoblastic Leukemia (B-ALL)
22%
BCP-ALL
24%
Bone Marrow
28%
CD19
43%
CD34+
33%
Cell Population
31%
Cellular Level
19%
Childhood Acute Lymphoblastic Leukemia
28%
Childhood Leukemia
23%
Children with Cancer
34%
Chimeric Antigen Receptor T Cells (CAR-T)
24%
Down Syndrome
20%
Drug Development
20%
Engraftment
33%
Event-free Survival
27%
Ewing Sarcoma Family of Tumors
64%
Flow Cytometric
25%
Fusion Gene
20%
Hematopoiesis
18%
Hematopoietic Stem Cell Transplantation
29%
High Risk
19%
Immune-deficient Mice
33%
Immunophenotyping
20%
In Vivo Model
18%
Individualized Therapy
20%
Leukemia
67%
Leukemia Patients
44%
Leukemic Cells
20%
Older Adults
29%
Pediatric
45%
Phase II Trial
20%
Positron Emission Tomography/computed Tomography (PET/CT)
29%
Relapsed/refractory
28%
RNA Sequencing (RNA-seq)
26%
SCID Mice
25%
Stem Cell Population
26%
Stem Cell Transplantation
27%
T Cells
29%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
24%
Tumor
36%
Tumor Cell Density
18%
Tumor Cell Lines
21%
Tumor Cells
28%
Tumor Subpopulations
19%
Whole-body PET
19%
Xenograft Model
22%
Medicine and Dentistry
(3 Iodobenzyl)guanidine
17%
3 Hydroxyephedrine
17%
Acute Leukemia
13%
Acute Lymphoblastic Leukemia
38%
Acute Lymphocytic Leukemia
20%
Acute Myelogenous Leukemia
22%
Acute Myeloid Leukemia
82%
Adolescence
31%
Allogeneic Stem Cell Transplantation
17%
B Cell
30%
Carbon 11
17%
Chemotherapy
13%
Childhood Cancer
31%
Clinical Trial
17%
Diseases
18%
Down Syndrome
26%
Engraftment
21%
Event Free Survival
17%
Ewing Sarcoma
28%
Experimental Therapy
13%
Hematopoietic Cell
10%
Hematopoietic Stem Cell Transplantation
20%
Immunophenotyping
12%
Immunotherapy
26%
Iodine 123
17%
Leukemia
49%
Leukemia in Children
21%
Malignant Neoplasm
41%
Metastatic Carcinoma
19%
Myelodysplastic Syndrome
18%
Neoplasm
12%
Oncology
16%
Osteosarcoma
11%
Pediatric Cancer
21%
Pediatrics
56%
Personalized Medicine
17%
Positron Emission Tomography
11%
Positron Emission Tomography-Computed Tomography
19%
Precursor
22%
Radioactive Tracer
17%
Reduced Intensity Conditioning
14%
SCID Mouse
29%
Single Photon Emission Computed Tomography-Computed Tomography
17%
Stem Cell
15%
Survival Rate
13%
Sympathetic Nervous System
17%
Tumor
47%
Tumor Cell
14%
Whole Body PET
19%
Xenograft
29%
Immunology and Microbiology
Adolescence
8%
Allogeneic Stem Cell Transplantation
28%
Antigen
17%
B Cell
57%
Bone Marrow Cell
11%
Bone Marrow Transplantation
8%
CD11a
8%
CD19
47%
CD34
58%
CD38
9%
Cell Adhesion Proteins
15%
Cell Antigen
9%
Cell Level
19%
Cell Population
31%
Cell Subpopulation
21%
Cell Transplantation
10%
Central Nervous System
17%
Content Analysis
8%
Cord Blood Stem Cell Transplantation
11%
Cytokine
31%
Cytokine Receptor
11%
DNA Content
12%
Engraftment
28%
Event Free Survival
30%
Hematopoiesis
31%
Hematopoietic Cell
18%
Hematopoietic Stem Cell Transplantation
17%
High Risk Population
13%
Human Cell
15%
Immunotherapy
37%
In Vitro
15%
Leukemia Cell
20%
Lineages
15%
Mediator
8%
Murine
10%
Myeloid
44%
NOD SCID Mouse
18%
Precursor
43%
Programmed Cell Death
16%
Regulator Gene
8%
SCID Mouse
55%
Stem Cell
44%
Stem Cell Transplantation
19%
Steroid
8%
Survival Rate
13%
T Cell
47%
Tumor Cell
25%
Tumor Cell Line
17%
Tumor Immunity
8%
Xenograft
24%
